SitesBLAST
Comparing WP_012589784.1 NCBI__GCF_000021745.1:WP_012589784.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
5oqtA Crystal structure of a bacterial cationic amino acid transporter (cat) homologue (see paper)
51% identity, 95% coverage: 21:489/494 of query aligns to 13:455/456 of 5oqtA
- binding alanine: I38 (= I46), G40 (= G48), T41 (≠ A49), G42 (= G50), F226 (= F260), A227 (= A261), I229 (= I263)
- binding : E24 (≠ T32), G26 (≠ S34), F28 (≠ A36), D29 (≠ S37), M32 (≠ S40), A176 (= A196), R177 (≠ K197), A184 (= A204), A188 (= A208), L192 (≠ V212), Q294 (≠ L328), V297 (≠ L331)
6f34A Crystal structure of a bacterial cationic amino acid transporter (cat) homologue bound to arginine. (see paper)
51% identity, 95% coverage: 21:489/494 of query aligns to 15:457/458 of 6f34A
- binding arginine: I40 (= I46), G42 (= G48), T43 (≠ A49), G44 (= G50), E115 (= E121), Y116 (= Y122), A119 (≠ G125), F228 (= F260), A229 (= A261), I231 (= I263), V314 (= V346)
- binding cholesterol: W201 (≠ S219), Y202 (≠ S220)
- binding : G28 (≠ S34), F30 (≠ A36), D31 (≠ S37), M34 (≠ S40), A178 (= A196), R179 (≠ K197), A186 (= A204), I187 (= I205), A190 (= A208), L194 (≠ V212), Q296 (≠ L328), V299 (≠ L331)
P30825 High affinity cationic amino acid transporter 1; CAT-1; CAT1; Ecotropic retroviral leukemia receptor homolog; Ecotropic retrovirus receptor homolog; Solute carrier family 7 member 1; System Y+ basic amino acid transporter from Homo sapiens (Human) (see paper)
37% identity, 83% coverage: 25:432/494 of query aligns to 24:436/629 of P30825
- N226 (= N231) modified: carbohydrate, N-linked (GlcNAc...) asparagine
P76037 Putrescine importer PuuP from Escherichia coli (strain K12) (see paper)
26% identity, 94% coverage: 28:489/494 of query aligns to 17:448/461 of P76037
- Y110 (= Y122) mutation to X: The uptake activity is reduced to one-eighth of that of wild-type.
Q7YQK4 Large neutral amino acids transporter small subunit 1; 4F2 light chain; 4F2 LC; 4F2LC; L-type amino acid transporter 1; LAT1; Solute carrier family 7 member 5 from Oryctolagus cuniculus (Rabbit) (see 2 papers)
26% identity, 95% coverage: 12:480/494 of query aligns to 25:469/503 of Q7YQK4
- C88 (≠ A74) mutation to S: No significant effect on inhibition by HgCl(2). Decreased KM and Vmax for Phe. Similar affect on KM and Vmax for Phe; when associated with S-183.
- C98 (= C84) mutation to S: No significant effect on inhibition by HgCl(2). Slightly decreased KM and Vmax for Phe. Slightly less decreased KM and Vmax for Phe; when associated with S-183.
- C160 (≠ W166) mutation to S: No change to KM or Vmax for Phe.
- C172 (≠ V178) mutation to S: No change to KM or Vmax for Phe.
- C174 (≠ I180) mutation to S: No change to KM or Vmax for Phe.
- C183 (≠ V189) mutation to S: No significant effect on inhibition by HgCl(2). Slightly decreased KM and Vmax for Phe. Similar affect on KM and Vmax for Phe; when associated with S-88. Slightly less decreased KM and Vmax for Phe; when associated with S-98.
- G219 (≠ N225) mutation to D: Decreased KM and Vmax for Trp. Increased KM and Vmax for Phe; when associated with L-234.
- W234 (≠ A241) mutation to L: Decreased KM and Vmax for Trp. Increased KM but decreased Vmax for Phe. Increased KM and Vmax for Phe; when associated with D-219.
- C331 (≠ L343) mutation to S: No significant effect on inhibition by HgCl(2). Increased KM and Vmax for Phe.
- C377 (≠ G389) mutation to S: No significant effect on inhibition by HgCl(2).
- C403 (≠ A415) mutation to S: No significant effect on inhibition by HgCl(2).
- C439 (≠ P447) mutation to S: Prevents insertion into the plasma membrane and possibly protein folding.
- C454 (≠ T464) mutation to S: No significant effect on inhibition by HgCl(2). Slightly increased KM but slightly decreased Vmax for Phe.
Sites not aligning to the query:
- 492 C→S: No significant effect on inhibition by HgCl(2). Slightly decreased KM and Vmax for Phe.
8xxiA Structure of y+lat1 bound with leu
24% identity, 94% coverage: 25:488/494 of query aligns to 1:440/465 of 8xxiA
8xyjA Structure of y+lat1 bound with lys
24% identity, 94% coverage: 25:488/494 of query aligns to 1:440/459 of 8xyjA
Q9QXW9 Large neutral amino acids transporter small subunit 2; L-type amino acid transporter 2; mLAT2; Solute carrier family 7 member 8 from Mus musculus (Mouse) (see paper)
26% identity, 86% coverage: 19:442/494 of query aligns to 25:424/531 of Q9QXW9
- Y130 (= Y122) mutation to A: Increases T2 import. Increases T3 and enables T4 import. Does not affect L-leucine and L-phenylalanine uptake.
- N133 (≠ G125) mutation to S: Increases T2 import. Does not affect T3 import. Does not affect L-leucine and L-phenylalanine uptake. Increases the export of both L-leucine and L-phenylalanine.
- F242 (= F260) mutation to W: Increases T2 import. Does not affect T3 import. Does not affect L-leucine and L-phenylalanine uptake.
P82251 b(0,+)-type amino acid transporter 1; b(0,+)AT1; Glycoprotein-associated amino acid transporter b0,+AT1; Solute carrier family 7 member 9 from Homo sapiens (Human) (see 11 papers)
23% identity, 95% coverage: 14:482/494 of query aligns to 8:454/487 of P82251
- V40 (≠ I43) to M: in CSNU; uncertain significance
- IIGSG 43:47 (≠ IIGAG 46:50) binding L-arginine
- I44 (= I47) to T: in CSNU; type I; dbSNP:rs121908485
- S51 (≠ L54) to F: in CSNU; uncertain significance
- P52 (≠ T55) to L: in CSNU; impairs protein stability and dimer formation; dbSNP:rs1198613438
- A70 (≠ V72) to V: in CSNU; partial loss of amino acid transport activity; dbSNP:rs769448665
- Y99 (= Y101) to H: in CSNU; uncertain significance
- G105 (= G107) to R: in CSNU; type III; severe loss of amino acid transport activity; dbSNP:rs121908480
- W114 (= W116) to R: in CSNU; uncertain significance
- I120 (≠ E121) to L: in CSNU; uncertain significance
- T123 (≠ F124) to M: in CSNU; partial loss of amino acid transport activity; dbSNP:rs79987078
- V142 (≠ I146) to A: no effect on amino acid transport activity; dbSNP:rs12150889
- C144 (≠ I148) modified: Interchain (with C-114 in SLC3A1)
- V170 (= V192) to M: in CSNU; type III; severe loss of amino acid transport activity; dbSNP:rs121908479
- A182 (= A204) to T: in CSNU; type III; partial loss of amino acid transport activity; dbSNP:rs79389353
- G195 (= G217) to R: in CSNU; type III; decreased amino acid transport activity; dbSNP:rs121908482
- L223 (vs. gap) to M: slightly decreased amino acid transport activity; dbSNP:rs1007160
- A224 (vs. gap) to V: in CSNU; non-classic type I; dbSNP:rs140873167
- N227 (≠ S249) to D: in CSNU; decreased amino acid transport activity
- W230 (≠ F260) to R: in CSNU; complete loss of amino acid transport activity; mutation to A: Abolishes amino acid transport activity.
- D233 (≠ I263) binding L-arginine; mutation to A: Complete loss of amino acid transport activity.
- W235 (≠ F265) mutation to A: Complete loss of amino acid transport activity.
- Q237 (≠ A267) mutation to A: Reduces amino acid transport activity.
- G259 (≠ S289) to R: in CSNU; type III; impairs protein stability and dimer formation; dbSNP:rs121908483
- P261 (≠ V291) to L: in CSNU; types I and III; dbSNP:rs121908486
- S286 (≠ P316) to F: in CSNU; uncertain significance; dbSNP:rs755135545
- C321 (≠ L351) mutation to S: Does not affect amino acid transport activity.
- A324 (≠ Q354) to E: in CSNU; uncertain significance
- V330 (≠ S360) to M: in CSNU; type III; dbSNP:rs201618022
- A331 (≠ I361) to V: in CSNU; non-classic type I; dbSNP:rs768466784
- R333 (= R363) to Q: in CSNU; decreased amino acid transport activity; dbSNP:rs769576205; to W: in CSNU; severe loss of amino acid transport activity; dbSNP:rs121908484
- A354 (≠ T384) to T: in CSNU; type III; severe loss of amino acid transport activity; dbSNP:rs939028046
- S379 (≠ A415) mutation to A: Markedly reduces amino acid transport activity.
- A382 (vs. gap) to T: in CSNU; severe loss of amino acid transport activity; dbSNP:rs774878350
- W383 (vs. gap) mutation to A: Complete loss of amino acid transport activity.
- Y386 (vs. gap) mutation to A: Loss of amino acid transport activity.
- K401 (≠ P431) to E: in CSNU; uncertain significance; dbSNP:rs760264924
- L426 (= L456) to P: in CSNU; uncertain significance
Sites not aligning to the query:
- 482 P → L: in CSNU; severe loss of amino acid transport activity; no effect on localization to the apical membrane; dbSNP:rs146815072; mutation P->A,G,S,V: No effect on amino acid transport activity.; mutation P->F,I,M,W: Decreased amino acid transport activity.
Q9UHI5 Large neutral amino acids transporter small subunit 2; L-type amino acid transporter 2; hLAT2; Solute carrier family 7 member 8 from Homo sapiens (Human) (see 3 papers)
25% identity, 84% coverage: 29:442/494 of query aligns to 36:425/535 of Q9UHI5
- I53 (= I46) binding L-leucine
- Y93 (= Y85) mutation to A: Nearly complete reduction of glycine, L-alanine, and L-glutamine uptake. Minimal effect on the transport of L-isoleucine, L-histidine and L-tryptophan.
- N134 (≠ G125) Important for substrate specificity; binding L-tryptophan; mutation to Q: Reduces L-leucine uptake activity. Abolishes L-tryptophan uptake.; mutation to S: The substrate specificity changed dramatically reducing L-glutamine, glycine and L-alanine uptake activity thus mimicking the selectivity of SLC7A5.
- C154 (≠ A158) modified: Interchain (with C-210 in SLC3A2)
- W174 (≠ A186) mutation to A: Does not affect protein expression, plasma membrane localization, or L-alanine uptake.
- F243 (= F260) mutation to A: Abolishes leucine and tryptophan transport activities.
- G246 (≠ I263) Important for substrate specificity; binding L-leucine; mutation to S: Strong decrease in the uptake of large substrates L-tryptophan, L-glutamine, and L-histidine but increases the uptake of small neutral amino acids glycine and L-alanine.
- V302 (≠ D317) to I: found in a patient with age-related hearing loss; does not affect L-alanine transport activity. Decreases L-tyrosine transport activity; dbSNP:rs142951280
- N395 (≠ G411) binding L-tryptophan; mutation to Q: Strongly reduces L-leucine uptake activity. Strongly reduces L-tryptophan uptake activity.
- Y396 (≠ T412) mutation to A: Strongly reduces L-leucine uptake activity.
- T402 (≠ V419) to M: found in a patient with age-related hearing loss; strongly decreased L-alanine transport activity. Decreases L-tyrosine transport activity; dbSNP:rs758342760
- R418 (= R435) to C: found in a patient with age-related hearing loss; decreases L-alanine transport activity. Decreases L-tyrosine transport activity; dbSNP:rs146946494
Sites not aligning to the query:
- 460 V → E: found in a patient with age-related hearing loss; strongly decreases L-alanine transport activity. Decreases L-tyrosine transport activity. Decreases cell membrane localization; dbSNP:rs2048595742
Q01650 Large neutral amino acids transporter small subunit 1; 4F2 light chain; 4F2 LC; 4F2LC; CD98 light chain; Integral membrane protein E16; E16; L-type amino acid transporter 1; hLAT1; Solute carrier family 7 member 5; y+ system cationic amino acid transporter from Homo sapiens (Human) (see 3 papers)
25% identity, 92% coverage: 25:480/494 of query aligns to 42:473/507 of Q01650
- Y117 (= Y99) mutation to A: Strongly decreased leucine transport activity.
- C164 (≠ I148) modified: Interchain (with C-210 in SLC3A2)
- D223 (≠ N225) to V: in dbSNP:rs17853937
- N230 (≠ D233) to K: in dbSNP:rs1060250
- A246 (≠ G254) mutation to V: Nearly abolishes leucine transport activity.
- F252 (= F260) mutation to A: Nearly abolishes leucine transport activity.
- W257 (≠ F265) mutation to A: Nearly abolishes leucine transport activity.
- N258 (≠ D266) mutation to A: Decreased leucine transport activity.; mutation to D: Nearly abolishes leucine transport activity.
- Y259 (≠ A267) mutation to A: Strongly decreased leucine transport activity.
- E303 (≠ D311) mutation to K: Decreased leucine transport activity.
- P375 (≠ L383) mutation to L: Nearly abolishes leucine transport activity.
Sites not aligning to the query:
- 483:507 mutation Missing: Nearly abolishes leucine transport activity.
8j8mB Overall structure of the lat1-4f2hc bound with tryptophan
25% identity, 91% coverage: 29:480/494 of query aligns to 3:430/463 of 8j8mB
8j8lB Overall structure of the lat1-4f2hc bound with l-dopa
25% identity, 91% coverage: 29:480/494 of query aligns to 3:430/463 of 8j8lB
8x0wB Overall structure of the lat1-4f2hc bound with leu
25% identity, 91% coverage: 29:480/494 of query aligns to 3:430/464 of 8x0wB
8idaB Overall structure of the lat1-4f2hc bound with tyrosine
25% identity, 91% coverage: 29:480/494 of query aligns to 3:430/464 of 8idaB
7dsqB Overall structure of the lat1-4f2hc bound with 3,5-diiodo-l-tyrosine (see paper)
25% identity, 91% coverage: 29:480/494 of query aligns to 3:430/464 of 7dsqB
7dsnB Overall structure of the lat1-4f2hc bound with jx-119 (see paper)
25% identity, 91% coverage: 29:480/494 of query aligns to 3:430/464 of 7dsnB
- binding (2~{S})-2-azanyl-7-[[2-(1,3-benzoxazol-2-yl)phenyl]methoxy]-3,4-dihydro-1~{H}-naphthalene-2-carboxylic acid: T19 (≠ C45), I20 (= I46), G22 (= G48), S23 (≠ A49), G24 (= G50), I97 (≠ E121), I104 (≠ T128), F209 (= F260), A210 (= A261), G212 (≠ I263), I354 (≠ G405), N361 (≠ T412)
- binding cholesterol hemisuccinate: F109 (≠ W133), Y145 (≠ V190), K148 (≠ N193), V153 (= V198), Q326 (≠ R377)
Sites not aligning to the query:
7dslB Overall structure of the lat1-4f2hc bound with jx-078 (see paper)
25% identity, 91% coverage: 29:480/494 of query aligns to 3:430/464 of 7dslB
7dskB Overall structure of the lat1-4f2hc bound with jx-075 (see paper)
25% identity, 91% coverage: 29:480/494 of query aligns to 3:430/464 of 7dskB
- binding (2~{S})-2-azanyl-7-(naphthalen-1-ylmethoxy)-3,4-dihydro-1~{H}-naphthalene-2-carboxylic acid: T19 (≠ C45), I20 (= I46), S23 (≠ A49), G24 (= G50), I97 (≠ E121), S100 (≠ F124), S101 (≠ G125), F209 (= F260), G212 (≠ I263), Y216 (≠ A267), V353 (= V404), I354 (≠ G405), N361 (≠ T412)
- binding cholesterol hemisuccinate: K148 (≠ N193), A149 (≠ E194), V153 (= V198), F157 (≠ I202), H324 (= H375)
Sites not aligning to the query:
7b00A Human lat2-4f2hc complex in the apo-state (see paper)
25% identity, 83% coverage: 35:442/494 of query aligns to 2:385/457 of 7b00A
Sites not aligning to the query:
Query Sequence
>WP_012589784.1 NCBI__GCF_000021745.1:WP_012589784.1
MTSIWSTKSIASLKAEAHEAEFGSETPNLRRTLSLASLISLGIGCIIGAGIFVLTGHAAA
AYAGPAISLSFVLAGLVCALAGLCYAEMASTVPVAGSAYTYAYATLGEFIAWIIGWDLLL
EYAFGATTVAIGWSGYVVSFLRDFHIGIPAALAGAPFAFDPASGAWTHTGALVNAPAVAI
VLALTALLVVGVNESAKVNNIIVAIKLAIIVVFILAGLSSVSTANWVTSANPDGAFIPPN
AGPGEYGWSGILRGAAVVFFAYIGFDAVSTAAQEAKNPQRDMPLGILGSLVICTVLYVLV
SIVITGIVPFDRLSVPDPIALGVDVIGLRWLSTVVKLGAILGLSSVVLVLLLGQTRVLYS
IARDGLLPPIAAKVHPRFRTPYLTTIGTGLIVAVMAGVLPIGLVGELVSIGTLFAFAIVC
AGVLFLRYTHPQIHRPFRAPLIAIVAPLGAAAAVVLMLGLPRDTWIRFAIWLAIGLILYF
TYGRRHSRLARAAE
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory